Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer

Nima Sharifi

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1239-1241
Number of pages3
JournalFuture Oncology
Volume7
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Androstadienes
Etiocholanolone
3-Hydroxysteroid Dehydrogenases
Androstenediol
Orchiectomy
Dehydroepiandrosterone
Dihydrotestosterone
Castration
Androgen Receptors
Antineoplastic Agents
Testosterone
Prostatic Neoplasms
Abiraterone Acetate

Keywords

  • 5α-androstanedione
  • abiraterone acetate
  • androgen receptor
  • dihydrotestosterone
  • prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer. / Sharifi, Nima.

In: Future Oncology, Vol. 7, No. 11, 11.2011, p. 1239-1241.

Research output: Contribution to journalArticle

@article{36e367b7a1444b2e9273a71120df0787,
title = "Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer",
keywords = "5α-androstanedione, abiraterone acetate, androgen receptor, dihydrotestosterone, prostate cancer",
author = "Nima Sharifi",
year = "2011",
month = "11",
doi = "10.2217/fon.11.98",
language = "English (US)",
volume = "7",
pages = "1239--1241",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "11",

}

TY - JOUR

T1 - Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer

AU - Sharifi, Nima

PY - 2011/11

Y1 - 2011/11

KW - 5α-androstanedione

KW - abiraterone acetate

KW - androgen receptor

KW - dihydrotestosterone

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=80455125996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455125996&partnerID=8YFLogxK

U2 - 10.2217/fon.11.98

DO - 10.2217/fon.11.98

M3 - Article

C2 - 22044197

AN - SCOPUS:80455125996

VL - 7

SP - 1239

EP - 1241

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 11

ER -